Eiwa Ishida
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
-
- Epigenetics and DNA Methylation 12
- Cell death mechanisms and regulation 8
- Cancer-related gene regulation 4
- Melanoma and MAPK Pathways 3
-
- Prostate Cancer Treatment and Research 10
- Co-authors
- Keiji Shimada (36 shared papers)Mitsutoshi Nakamura (35 shared papers)Noboru Konishi (34 shared papers)Munehiro Kishi (14 shared papers)Hiroyuki Nakase (6 shared papers)Toshisuke Sakaki (6 shared papers)Tomonori Higuchi (5 shared papers)M Nishimine (5 shared papers)
- Journals
- Pathology International (3 papers)Molecular Carcinogenesis (3 papers)Pathobiology (3 papers)Cancer Science (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Eiwa Ishida
51 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 81
- Cancer Research 297
- Genetics 166
- Molecular Biology 930
- Oncology 356
- Immunology and Allergy 64
Countries citing papers authored by Eiwa Ishida
This map shows the geographic impact of Eiwa Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiwa Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiwa Ishida more than expected).
Fields of papers citing papers by Eiwa Ishida
This network shows the impact of papers produced by Eiwa Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiwa Ishida. The network helps show where Eiwa Ishida may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiwa Ishida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. | 2003 | 98 |
| 2 | 2007 | 84 | |
| 3 | 2005 | 78 | |
| 4 | Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. | 2001 | 75 |
| 5 | 2002 | 71 | |
| 6 | 2005 | 66 | |
| 7 | 2007 | 66 | |
| 8 | 2004 | 61 | |
| 9 | 2002 | 58 | |
| 10 | 2002 | 44 | |
| 11 | 2005 | 42 | |
| 12 | 2006 | 39 | |
| 13 | 2008 | 38 | |
| 14 | 2003 | 36 | |
| 15 | 2003 | 34 | |
| 16 | 2006 | 33 | |
| 17 | 2005 | 32 | |
| 18 | 2006 | 28 | |
| 19 | Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas. | 2003 | 27 |
| 20 | 2005 | 26 |
About Eiwa Ishida
Eiwa Ishida is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 52 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), Prostate Cancer Treatment and Research (10 papers), Cancer-related Molecular Pathways (10 papers), Cell death mechanisms and regulation (8 papers), Cancer-related gene regulation (4 papers), Glioma Diagnosis and Treatment (4 papers), Melanoma and MAPK Pathways (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (297 citations), Genetics (166 citations), Molecular Biology (930 citations), Oncology (356 citations) and Immunology and Allergy (64 citations). Eiwa Ishida has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Keiji Shimada, Mitsutoshi Nakamura, Noboru Konishi, Munehiro Kishi, Hiroyuki Nakase, Toshisuke Sakaki, Tomonori Higuchi, M Nishimine, N Konishi and Kazutake Tsujikawa. Their work appears in journals such as Pathology International, Molecular Carcinogenesis, Pathobiology, Cancer Science and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.